Overview

Predictors of Opioid-Induced Respiratory Depression (OIRD)

Status:
Completed
Trial end date:
2018-04-29
Target enrollment:
Participant gender:
Summary
Purpose of the Study: (1) To classify an individual subject's ventilatory response in terms of respiratory depression to a bolus of remifentanil under normoxic and hyperoxic conditions. (2) Measurement of specific respiratory parameters to predict the opioid-induced respiratory depression (OIRD) response.
Phase:
Phase 1
Details
Lead Sponsor:
Duke University
Treatments:
Analgesics, Opioid
Remifentanil